What is NasaClip?
NasaClip is a pioneering startup dedicated to revolutionizing the treatment of nosebleeds. The company's flagship device offers a hands-free, painless solution by applying constant external nasal pressure, complemented by intranasal sponges that can be medicated for rapid bleeding cessation. This innovative approach aims to provide a more effective and comfortable alternative to traditional methods, addressing a common and often disruptive medical issue.
How much funding has NasaClip raised?
NasaClip has raised a total of $3.6M across 3 funding rounds:
Other Financing Round
$250K
Other Financing Round
$500K
Other Financing Round
$2.6M
Other Financing Round (2023): $250K with participation from Tedco
Other Financing Round (2023): $500K led by Tedco
Other Financing Round (2024): $2.6M, investors not publicly disclosed
Key Investors in NasaClip
Tedco
TEDCO, the Maryland Technology Development Corporation, is an organization focused on fostering an inclusive entrepreneurial innovation ecosystem. They identify, invest in, and help grow technology and life science-based companies within Maryland, indicating a strategic interest in innovative medical technology.
What's next for NasaClip?
With the infusion of major enterprise-level capital and a recent strategic investment, NasaClip is well-positioned for its next phase of development. The company is expected to leverage this financing to scale its operations, enhance its product offerings, and expand its market reach. Further strategic partnerships and product advancements are anticipated as NasaClip solidifies its presence in the medical device sector.
See full NasaClip company page
